- Joined
- Apr 18, 2015
- Messages
- 129
- Reaction score
- 65
Looking for wisdom from people who know what they're talking about with research & pubs!
Just heard today that I'll be getting a research letter placed in one of the top 3 journals as a middle author. The piece still needs to go through revise & resubmit, but the editors told my PI it will be published after we go through the motions. It's original research (even cutting edge & novel, some would argue 😛 ), but for complicated reasons we didn't see fit to write an entire 4000-word thing about it.
Obviously I'm very excited that the work will be in a high-impact journal. However, I also know research letter ≠ research article. My school app list is realistic, but I'm aiming high.
Three questions:
1) How are 800-word research letters in high-impact journals viewed? In the context of med school admissions and research more broadly.
2) Worthy of mention on my AMCAS (will submit on 6/2)? I have 1 other middle author pub and 1 non-peer reviewed NGO report.
3) If mentioning, should I put it under my pubs but just say that it's under R&R at NEJM/JAMA/Lancet?
Just heard today that I'll be getting a research letter placed in one of the top 3 journals as a middle author. The piece still needs to go through revise & resubmit, but the editors told my PI it will be published after we go through the motions. It's original research (even cutting edge & novel, some would argue 😛 ), but for complicated reasons we didn't see fit to write an entire 4000-word thing about it.
Obviously I'm very excited that the work will be in a high-impact journal. However, I also know research letter ≠ research article. My school app list is realistic, but I'm aiming high.
Three questions:
1) How are 800-word research letters in high-impact journals viewed? In the context of med school admissions and research more broadly.
2) Worthy of mention on my AMCAS (will submit on 6/2)? I have 1 other middle author pub and 1 non-peer reviewed NGO report.
3) If mentioning, should I put it under my pubs but just say that it's under R&R at NEJM/JAMA/Lancet?
Last edited: